191 related articles for article (PubMed ID: 14580759)
1. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.
Stratakis CA
Trends Endocrinol Metab; 2003 Nov; 14(9):404-10. PubMed ID: 14580759
[TBL] [Abstract][Full Text] [Related]
2. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
3. Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes.
Kitamura Y; Sasamura H; Maruyama T; Nakaya H; Amemiya T; Hayashi M; Saruta T
Mol Cell Endocrinol; 1998 Sep; 144(1-2):37-45. PubMed ID: 9863625
[TBL] [Abstract][Full Text] [Related]
4. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
5. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
6. 5th International ACC Symposium: The New Genetics of Benign Adrenocortical Neoplasia: Hyperplasias, Adenomas, and Their Implications for Progression into Cancer.
Kirschner LS; Stratakis CA
Horm Cancer; 2016 Feb; 7(1):9-16. PubMed ID: 26684645
[TBL] [Abstract][Full Text] [Related]
7. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
Giordano TJ
Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
[No Abstract] [Full Text] [Related]
8. MEN1 gene mutation analysis of sporadic adrenocortical lesions.
Görtz B; Roth J; Speel EJ; Krähenmann A; De Krijger RR; Matias-Guiu X; Muletta-Feurer S; Rütmann K; Saremaslani P; Heitz PU; Komminoth P
Int J Cancer; 1999 Jan; 80(3):373-9. PubMed ID: 9935177
[TBL] [Abstract][Full Text] [Related]
9. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
10. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
Lin SR; Tsai JH; Yang YC; Lee SC
Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
13. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
[TBL] [Abstract][Full Text] [Related]
14. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
[TBL] [Abstract][Full Text] [Related]
15. Medicine. A unified cause for adrenal Cushing's syndrome.
Kirschner LS
Science; 2014 May; 344(6186):804-5. PubMed ID: 24855241
[No Abstract] [Full Text] [Related]
16. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
[TBL] [Abstract][Full Text] [Related]
17. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
[TBL] [Abstract][Full Text] [Related]
19. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
[TBL] [Abstract][Full Text] [Related]
20. Analysis of numerical chromosomal aberrations in adrenal cortical neoplasms by fluorescence in situ hybridization.
Shono T; Sakai H; Takehara K; Honda S; Kanetake H
J Urol; 2002 Oct; 168(4 Pt 1):1370-3. PubMed ID: 12352395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
